Polyfunctionality of CD4 + T lymphocytes is increased after chemoradiotherapy of head and neck squamous cell carcinoma
ConclusionCRT increases polyfunctionality of CD4+ T cells in HNSCC patients, suggesting that standard-of-care therapy can promote immune activity in immune cells. These polyfunctional CD4+ T cells in the blood of treated HNSCC patients are expected to be responsive to subsequent immunotherapeutic approaches.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Head and Neck Cancer | HNSCC | Immunotherapy | Skin Cancer | Squamous Cell Carcinoma